POPULATION-BASED FREQUENCY OF DYSLIPIDEMIA SYNDROMES IN CORONARY-PRONE FAMILIES IN UTAH

被引:73
作者
WILLIAMS, RR
HOPKINS, PN
HUNT, SC
WU, LL
HASSTEDT, SJ
LALOUEL, JM
ASH, KO
STULTS, BM
KUIDA, H
机构
[1] UNIV UTAH, DEPT MED, SALT LAKE CITY, UT 84112 USA
[2] UNIV UTAH, DEPT PATHOL, SALT LAKE CITY, UT 84112 USA
[3] UNIV UTAH, DEPT HUMAN GENET, SALT LAKE CITY, UT 84112 USA
关键词
D O I
10.1001/archinte.150.3.582
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The frequency of familial dyslipidemia syndromes was determined from blood tests in 33 objectively ascertained families with early coronary heart disease (CHD) (two or more siblings with CHD by the age of 55 years). Three fourths of persons with early CHD in these families had 90th percentile lipid abnormalities (cholesterol level at or above the 90th percentile, triglyceride level at or above the 90th percentile, and/or high-density lipoprotein cholesterol (HDL-C) level at or less than the 10th percentile). The HDL-C and triglyceride abnormalities were twice as common as low-density lipoprotein-cholesterol abnormalities. The most common syndromes found were familial combined hyperlipidemia (36% to 48% of families with CHD), familial dyslipidemic hypertension (21% to 54% of families with CHD), and isolated low levels of HDL-C (15%), with overlapping familial dyslipidemic hypertension with familial combined hyperlipidemia and low-level HDL-C. Well-defined monogenic syndromes were uncommon: familial hypercholesterolemia being 3% and familial type III hyperlipidemia, 3%. Another 15% of families with CHD had no lipid abnormalities at the 90th percentile. Physicians should learn to recognize and treat these common familial syndromes before the onset of CHD by evaluating family history and all three standard blood lipid determinations. Failure to recognize and treat them leaves affected family members at high risk of premature CHD.
引用
收藏
页码:582 / 588
页数:7
相关论文
共 29 条
  • [1] ARMITAGE P, 1973, STATISTICAL METHODS, P111
  • [2] BERNSTEIN MJ, 1985, JAMA-J AM MED ASSOC, V253, P2080
  • [3] CLEEMAN JI, 1988, ARCH INTERN MED, V148, P36, DOI 10.1001/archinte.148.1.36
  • [4] HYPERLIPIDEMIA IN CORONARY HEART-DISEASE .2. GENETIC ANALYSIS OF LIPID-LEVELS IN 176 FAMILIES AND DELINEATION OF A NEW INHERITED DISORDER, COMBINED HYPERLIPIDEMIA
    GOLDSTEIN, JL
    SCHROTT, HG
    HAZZARD, WR
    BIRMAN, EL
    MOTULSKY, AG
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (07) : 1544 - 1568
  • [5] PRIMARY TYPE 5 HYPERLIPOPROTEINEMIA - DESCRIPTIVE STUDY IN 32 FAMILIES
    GREENBERG, BH
    BLACKWELDER, WC
    LEVY, RI
    [J]. ANNALS OF INTERNAL MEDICINE, 1977, 87 (05) : 526 - 534
  • [6] GROVE TH, 1979, CLIN CHEM, V25, P560
  • [7] GRUNDY SM, 1987, ARTERIOSCLEROSIS, V7, P203
  • [8] THE PLACE OF HDL IN CHOLESTEROL MANAGEMENT - A PERSPECTIVE FROM THE NATIONAL CHOLESTEROL EDUCATION-PROGRAM
    GRUNDY, SM
    GOODMAN, DS
    RIFKIND, BM
    CLEEMAN, JI
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1989, 149 (03) : 505 - 510
  • [9] HASSTEDT SJ, 1988, AM J HUM GENET, V43, P14
  • [10] HOPKINS PN, 1984, WESTERN J MED, V141, P196